Related Experiment Videos
Effect of IV Hydrocortisone on Mortality among Neonates with Hypotension: A Systematic Review and Meta-analysis of
Chia Siang Kow1, Kaeshaelya Thiruchelvam2
1, MPharm, is with the School of Pharmacy, IMU University, Kuala Lumpur, Malaysia, and the School of Applied Sciences, University of Huddersfield, Huddersfield, United Kingdom.
Background:
Hypotension is common among preterm and term neonates in the neonatal intensive care unit, particularly those with very low birth weight, sepsis, or hypoxic-ischemic encephalopathy. Some remain hypotensive despite volume expansion and vasopressors, possibly due to relative adrenal insufficiency. Hydrocortisone is proposed as adjunct therapy, but its effect on mortality is uncertain.
Objective:
To evaluate whether IV hydrocortisone reduces all-cause mortality in neonates with hypotension.
Methods:
The MEDLINE, Embase, CENTRAL, and Scopus databases were searched up to March 30, 2025, for randomized controlled trials (RCTs) that compared IV hydrocortisone with placebo and reported mortality. Two reviewers independently screened the studies, extracted data, and assessed bias. A fixed-effects Mantel-Haenszel meta-analysis was used, based on the degree of heterogeneity.
Results:
Five RCTs (with a total of 239 neonates) were included. Heterogeneity was low (I 2 = 0%). Hydrocortisone significantly reduced mortality (odds ratio 0.48, 95% confidence interval 0.24-0.96).
Conclusions:
IV hydrocortisone may reduce mortality in refractory neonatal hypotension. However, larger trials are needed to confirm this finding.
Related Concept Videos
01:29Drug Dosing: Infants and Children
01:27Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
01:29Hypertension II: Pathophysiology